These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30256033)

  • 21. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B; Visser N; Theron J; Rieder E; Maree FF
    J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle.
    Zhang Z; Pan L; Ding Y; Zhou P; Lv J; Chen H; Fang Y; Liu X; Chang H; Zhang J; Shao J; Lin T; Zhao F; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1389-98. PubMed ID: 25381487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
    Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation.
    Kotecha A; Zhang F; Juleff N; Jackson T; Perez E; Stuart D; Fry E; Charleston B; Seago J
    J Gen Virol; 2016 Jul; 97(7):1557-1565. PubMed ID: 27002540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and evaluation of a recombinant foot-and-mouth disease virus: implications for inactivated vaccine production.
    Van Rensburg HG; Mason PW
    Ann N Y Acad Sci; 2002 Oct; 969():83-7. PubMed ID: 12381568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Foot-and-mouth disease vaccines.
    Diaz-San Segundo F; Medina GN; Stenfeldt C; Arzt J; de Los Santos T
    Vet Microbiol; 2017 Jul; 206():102-112. PubMed ID: 28040311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development.
    Puckette M; Clark BA; Smith JD; Turecek T; Martel E; Gabbert L; Pisano M; Hurtle W; Pacheco JM; Barrera J; Neilan JG; Rasmussen M
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T
    Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological responses of cattle inoculated with inactivated trivalent foot-and-mouth disease vaccine at the wildlife-livestock interface of the Kruger National Park, South Africa.
    Lazarus DD; van Schalkwyk OL; Burroughs REJ; Mpehle A; Reininghaus B; Rikhotso O; Heath L; Maree FF; Blignaut B; Fosgate GT
    Prev Vet Med; 2018 Oct; 158():89-96. PubMed ID: 30220400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
    McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
    J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced protection against FMDV in cattle after prime- boost vaccination based on mucosal and inactivated FMD vaccine.
    Khalifa ME; El-Deeb AH; Zeidan SM; Hussein HA; Abu-El-Naga HI
    Vet Microbiol; 2017 Oct; 210():1-7. PubMed ID: 29103677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
    De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
    Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foot-and-mouth disease vaccines: recent updates and future perspectives.
    Kamel M; El-Sayed A; Castañeda Vazquez H
    Arch Virol; 2019 Jun; 164(6):1501-1513. PubMed ID: 30888563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
    Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R
    Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The need for improved vaccines against foot-and-mouth disease.
    de Los Santos T; Diaz-San Segundo F; Rodriguez LL
    Curr Opin Virol; 2018 Apr; 29():16-25. PubMed ID: 29544088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient gene expression in serum-free suspension-growing mammalian cells for the production of foot-and-mouth disease virus empty capsids.
    Mignaqui AC; Ruiz V; Perret S; St-Laurent G; Singh Chahal P; Transfiguracion J; Sammarruco A; Gnazzo V; Durocher Y; Wigdorovitz A
    PLoS One; 2013; 8(8):e72800. PubMed ID: 23977353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa.
    Jackson B; Harvey Y; Perez-Martin E; Wilsden G; Juleff N; Charleston B; Seago J
    Vaccine; 2021 Aug; 39(35):5015-5024. PubMed ID: 34303562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.